Recent Headlines
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
GenScript Launches Rush Gene Synthesis Service
Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in the global market. - December 27, 2011 - GenScript USA Inc.
AnaSpec Highlights HiLyte Fluor™ Dyes Collection - for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - December 21, 2011 - AnaSpec, EGT Group
GenScript Sponsors 2011 iGEM Undergraduate Synthetic Biology Competition
Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams they sponsored in 2011 iGEM undergraduate synthetic biology competition. The iGEM teams have utilized GenScript’s gene synthesis service to build novel... - December 17, 2011 - GenScript USA Inc.
Arganworks Launches with 100 Percent Pure Argan Oil as the Foundation of Its Line
New Los Angeles Company Brings Rich Benefits of Moroccan Argan Oil to Beauty, Health and Dollar Conscious Consumers - November 24, 2011 - Arganworks, LLC
RayBiotech, Inc. Engages Industry Expert for Business Development & Growth Advisory Services
RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities. - November 10, 2011 - RayBiotech, Inc
VP at OSO BioPharmaceuticals Elected to DCAT Board of Directors
Milton Boyer to serve three-year term at leading industry association. - November 03, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces SensoLyte® Deubiquitination Assay Kit
AnaSpec, EGT Group, is pleased to introduce the SensoLyte® 440 Deubiquitination Assay Kit. This kit provides a convenient assay for inhibitors/activators screening in deubiquitinylation or for continuous assay of enzyme activity. A natural substrate, ubiquitin, coupled with the AMC... - October 19, 2011 - AnaSpec, EGT Group
AnaSpec Includes Citrullinated Histone in GO® Peptides Collection
AnaSpec, the world’s largest provider of on-demand GO® peptides is pleased to offer a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone GO® Peptides now include citrullinated sequences in addition to sequences that... - October 19, 2011 - AnaSpec, EGT Group
Beating Recession Blues and Fighting TB Infection: Sino-UK Companies' TB Vaccine Partnership Deal
UK Cambridge based vaccine company ImmBio joined-up with Sinopharm Vaccine Institute to co-develop its T-BioVax Vaccine against TB Infection. ImmunoBiology Ltd, a vaccine R&D company based Babraham Research Campus near Cambridge UK recently signed initial cooperation agreement with LIBP a subsidiary company under Sinopharm’s biological products division – CNBG (China National Biotech Group) with close coordination by Cambridge based biopharma consultancy company – Link China Pharma Solutions. - October 15, 2011 - Link China Pharma Solutions
AnaSpec Offers Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research. This includes MOG proteins, peptides, antibodies and assay kits. Myelin Oligodendrocyte Glycoprotein (MOG), a protein with a molecular weight of 26- to 28-kDa,... - September 29, 2011 - AnaSpec, EGT Group
AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide
AnaSpec is pleased to support advances in MS research by providing MOG (35 - 55), mouse, rat, a key peptide that induces severe chronic experimental autoimmune encephalomyelitis in transgenic mice. - September 29, 2011 - AnaSpec, EGT Group
Launch of Biotechnology Portal cellexis.com – Marketing of Innovative Cell Culture Technology
atech system solutions Ltd. (“atech”) has launched the online service www.cellexis.com for marketing and distribution of innovative products and services in the field of cell culture technology. The online service www.cellexis.com is the portal for distribution of bioreactor systems that are marketed under the name “cellexis one” and services like the delivery of manufacturing processes for cell culture products according to international standards. - September 22, 2011 - atech system solutions Ltd.
atech system solutions Develops New Bioreactor Platform for Cell Culture-Based Manufacturing
The atech system solutions Ltd. presents a new generation of bioreactor systems for cell culture-based manufacturing of biopharmaceutical compounds. The new development comprises a platform technology with high performance, safety as well as environmental compatibility and simplification of cell culture-based manufacturing methods. The system platform will be marketed under the brand name “cellexis one.” - September 17, 2011 - atech system solutions Ltd.
Bencos Releases Bencos Shop Beta– Online Procurement System
Bencos Shop will enable all its users to place procurement requests for products & services for life sciences research. - September 12, 2011 - Bencos Research Solutions
AnaSpec Introduces Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide Anti-MOG (Myelin Oligodendrocyte Glycoprotein) ELISA assay kits. The SensoLyte® Anti-Human MOG (1-125) IgG Quantitation ELISA Kit, SensoLyte® Anti-Mouse MOG (1-125) and SensoLyte® Anti-Rat MOG (1-125) IgG ELISA assay kits are... - September 10, 2011 - AnaSpec, EGT Group
AnaSpec Provides Industry’s Largest Collection of Anti-Tau Antibodies
In Alzheimer’s disease (AD), the major pathological hallmarks are β-sheet aggregates of β-amyloid peptides in senile plaques and hyperphosphorylated tau protein in neurofibrillary tangles (NFT).1-2 AnaSpec, a provider of one of the world’s largest collections of β-amyloid... - September 10, 2011 - AnaSpec, EGT Group
AnaSpec Offers ClearPoint™ β-Amyloid Custom Peptide Synthesis Service
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents, also provides ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled... - August 24, 2011 - AnaSpec, EGT Group
AnaSpec Offers SensoLyte® 520 TACE Assay Kit
While fluorimetric assay kits for the detection and inhibitor screening of Tumor Necrosis Factor alpha (TNF-α) Converting Enzyme (TACE) currently exist, none of these have been able to take full advantage of the performance provided by long wavelength FRET technologies. AnaSpec’s... - August 24, 2011 - AnaSpec, EGT Group
Educational Seminar for Manufacturers
An educational seminar, focused on providing manufacturers with the latest research in corrosion and recent innovations in finishing lines will be held at K-State Salina on Wednesday, August 24 at 12:30. The first session will be presented by Dr. Vicki Gelling of North Dakota State University. Dr. - August 23, 2011 - Kasa Companies
AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine
AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - August 14, 2011 - AnaSpec, EGT Group
AnaSpec Highlights Calcein AM with High Purity Grades
AnaSpec is pleased to provide Calcein AM at two purity grades, >90% or >95%, as determined by HPLC. AnaSpec also offers the SensoLyte® Calcein Cell Viability Assay Kit - a rapid and sensitive assay to detect viable cells. This kit provides ample reagents (dye and assay buffer) for 1000... - August 14, 2011 - AnaSpec, EGT Group
GenScript Launches Animal Model Services Worldwide
Internationally recognized biology contract research organization GenScript USA Inc. today announced that it has launched a broad spectrum of Animal Model Services for researchers to investigate the efficacy and safety profile of drug candidates. The services include in vivo drug efficacy,... - August 10, 2011 - GenScript USA Inc.
Bencos Shifts Website Domain from .in to .com
Bencos Research Solutions Pvt. Ltd. is now available at www.bencoslife.com. - August 09, 2011 - Bencos Research Solutions
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says
A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc
AnaSpec Releases Anti-LL-37
AnaSpec is pleased to announce the release of a new anti-LL-37. Rabbit Anti-human Cathelicidin LL-37 polyclonal antibody was raised against a synthetic peptide from a sequence found within 134-170 amino acid residues (LL-37) of the LL-37 precursor human cationic antimicrobial protein, hCAP-18... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Expands SensoLyte® MMP Assay Kits Collection
Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Specializes in Custom Peptide Synthesis
Since 1993, AnaSpec has assisted scientists in the design and synthesis of >50,000 peptides. As a result, AnaSpec's combined knowledge and expertise provide premium solutions to its customers. AnaSpec routinely completes difficult peptide synthesis such as synthesis of long peptides... - July 15, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances
OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Offers Custom Assay Development Service
AnaSpec, EGT Group, provider of the long wavelength, ultra-sensitive SensoLyte® assay kits, is pleased to offer custom service for the development of assays. The long wavelength of SensoLyte® protease assays, many of which utilize the 5-FAM/QXL™ 520 and HiLyte Fluor™... - June 23, 2011 - AnaSpec, EGT Group
AnaSpec Highlights Anb-Wang Resin
Colorimetric based Peptide-p-Nitroanilide conjugates (peptide-pNAs), with absorbance at approximately 408 nm, have historically been and are still widely used substrates for the study of protease activity. However, the preparation of peptide-pNA presents technical challenges. The amino group of pNA... - June 23, 2011 - AnaSpec, EGT Group
Scisense Offers Educational Webinar “Exploring Synergies Between Echo and Pressure-Volume Systems” Featuring Dr. Kim Connelly
Webinar attendees will learn both the advantages and challenges of echocardiography and PV loop analysis. - June 04, 2011 - Scisense Systems Inc.
CELFIX Cosmeceuticals Announces Launch of DNA iQuad Infusion Total Eye Complex
Carefree Skincare is focused on developing and providing consumers with innovative and highly efficacious anti-aging products that enhance the health and appearance of aging skin. Products are marketed under the CELFIX Cosmeceuticals brand name. The CELFIX DNA focused skincare line’s primary focus is in providing topical skincare utilizing DNA Repair Enzyme Technology. - June 02, 2011 - CELFIX Cosmeceuticals
AnaSpec Introduces Anti- β-Amyloid
AnaSpec, Eurogentec Group is pleased to announce the release of two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42). These two antibodies are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA. - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Introduces Speedy 28-Day Custom Polyclonal Antibody Service
When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Offers High-Throughput Dispensing Service
AnaSpec, EGT Group is pleased to offer high-throughput dispensing service. Their commitment to supply the life science community with simple, affordable and innovative solutions has resulted in this service: bringing the advantages of automation within everyone’s reach. The fully equipped... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Introduces DPPIV Assay Kit
AnaSpec, EGT Group is pleased to introduce a new long wavelength fluorimetric assay kit for determining Dipeptidyl Peptidase IV (DPPIV) activity, the SensoLyte® Rh110 DPPIV Assay Kit. This kit contains a substrate that emits in the green range of 520 nm when cleaved by DPPIV. The kit provides a... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Highlights MMP Inhibitors
AnaSpec, Eurogentec Group, is pleased to release 11 MMP inhibitors to complement their wide offering of MMP SensoLyte® 520 and 490 fluorimetric kits, colorimetric kits, recombinant proteins, and Z-Fish™ antibodies (antibodies specific for zebrafish). These MMP inhibitors are small... - May 25, 2011 - AnaSpec, EGT Group
Scisense Offers an Educational Webinar Titled "Peer-Review Expectations of PV Loop Data" Featuring Dr. Marc Feldman (MD, FACC), University of Texas
Webinar attendees will gain insights about validating PV loop data. - May 21, 2011 - Scisense Systems Inc.
GenScript Launches eStainTM 2.0 Protein Staining System
Internationally recognized Contract Research Organization (CRO) GenScript USA Incorporation has launched eStainTM 2.0 Protein Staining System to replace the original eStainTM System. The eStainTM 2.0 System provides fast and convenient protein gel staining in 7 minutes or less and has improved the... - May 18, 2011 - GenScript USA Inc.
OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande
OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River. The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program). The P2... - May 13, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Eagle Biosciences Announces the Launch of Mouse Monoclonal Antibody Isotyping ELISA Kit
Eagle Biosciences introduces a simple ELISA where up to 12 individual samples can be assayed for heavy chain anti-IgG1, IgG2a, IgG2b, IgG3, IgA, and IgM as well as light chain kappa and lambda in one 96-well ELISA plate. - May 11, 2011 - Eagle Biosciences, Inc.
GenScript Continues Deploying New Websites in Europe
GenScript USA Inc. has launched new websites at www.genscript.fr in France and at www.genscript.es in Spain to offer easier access for local French and Spanish searchers. - May 01, 2011 - GenScript USA Inc.
Scisense, Inc. is Hosting a Hands-on Workshop Clinic to Assess Cardiac Function
Studying Pressure Volume Loops Using Large-Animal Models: New Insights, Latest Advancements in PV Loop Technology, and Hands-on Experience. This workshop is scheduled for September 2011. - April 28, 2011 - Scisense Systems Inc.
AnaSpec Introduces Industry’s First Zebrafish Specific Antibodies - Z-FishTM Anti-Lysozyme
AnaSpec, Eurogentec Group is pleased to be the first in the industry to establish a new product line of zebrafish specific (Z-Fish™) antibodies to support the increasing needs of researchers. In collaboration with the University of Utah, Salt Lake City, Utah, AnaSpec's Z-Fish™... - April 13, 2011 - AnaSpec, EGT Group
GenScript Will Launch Services with GANP® Technology for World Wide Market Excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP® mice from TransGenic Inc. to produce high-affinity antibodies to scientists. - March 25, 2011 - GenScript USA Inc.
Science of Cardiac Function Assessment Using Pressure Volume Loops Web Seminar
Online Educational Web Seminar to Explain the Pressure and Volume Changes During the Cardiac Cycle. Scisense Inc. hosts Dr. Richard Klabunde, author of “Cardiovascular Physiology Concepts,” to explain the significance of pressure and volume changes during the cardiac cycle on cardiovascular function, covering relationships such as ESPVR, PRSW, and EDPVR. - March 23, 2011 - Scisense Systems Inc.
GenScript Launches New Website in Germany
GenScript USA Inc. has launched a new website at www.genscript.de in Germany to offer easier access for local German searchers. - March 16, 2011 - GenScript USA Inc.
BioAtla and Charles River Partner for Integrated Biological Service for Preclinical Development
BioAtla and Charles River have recently partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers from the earliest stages of discovery all the way through IND. - March 09, 2011 - BioAtla